PA
SPCE icon

PharVision Advisers’s Virgin Galactic SPCE Stock Holding History

PharVision Advisers’s Portfolio SPCE Stock Details SPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,066
Closed -$42.7K – 984
2025
Q3 		$42.7K Buy
+11,066
New +$37.1K 0.02% 653
2025
Q1 		– Sell
-36,636
Closed -$215K – 497
2024
Q4 		$215K Buy
+36,636
New +$244K 0.18% 268

Other funds holding SPCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's SPCE Position: Q4 2025 in Review

PharVision Advisers sold out of Virgin Galactic (SPCE) in Q4 2025, closing a stake of 11,066 shares — an estimated $42.7K sold.

PharVision Advisers first reported a position in SPCE in Q4 2024 and held it in 2 quarters. The position peaked at $215K in Q4 2024. 153 funds tracked by Wall St. Rank hold SPCE as of Q4 2025.

  • PharVision Advisers reported no remaining Virgin Galactic position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 11,066 Virgin Galactic shares in Q4 2025, an estimated $42.7K.
  • PharVision Advisers first reported a position in Virgin Galactic in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Virgin Galactic position peaked at $215K in Q4 2024.
  • 153 funds tracked by Wall St. Rank held Virgin Galactic as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.